• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寡聚化的α-突触核蛋白在帕金森病患者的基础泪液中增加。

Oligomeric α-synuclein is increased in basal tears of Parkinson's patients.

机构信息

Department of Ophthalmology & Roski Eye Institute, Keck School of Medicine, Los Angeles, CA 90033-6103, USA.

Department of Pharmacology & Pharmaceutical Sciences, School of Pharmacy, Los Angeles, CA 90033-6103, USA.

出版信息

Biomark Med. 2019 Aug;13(11):941-952. doi: 10.2217/bmm-2019-0167. Epub 2019 Jul 2.

DOI:10.2217/bmm-2019-0167
PMID:31262201
Abstract

Secretion of proteins into basal tears of Parkinson's disease (PD) patients may be altered by changes in nerve function. Oligomeric α-Syn and total α-Syn, CCL-2, DJ-1, LF and MMP-9 were measured in basal tears from 93 PD patients and 82 age- and sex-equivalent healthy controls. α-Syn was decreased (p = 0.0043), whereas α-Syn (p < 0.0001) and the ratio of α-Syn/α-Syn (p < 0.0001) were increased in basal tears from PD patients compared with healthy controls. Area under receiver-operating curves of α-Syn and α-Syn/α-Syn contents were 0.70 (95% confidence limits: 0.621-0.774) and 0.72 (95% confidence limits: 0.642-0.792). PD patient basal tears may contain biomarkers that can be assayed noninvasively and inexpensively.

摘要

帕金森病 (PD) 患者基础泪液中的蛋白质分泌可能会因神经功能的改变而发生变化。在 93 名 PD 患者和 82 名年龄和性别匹配的健康对照者的基础泪液中测量了寡聚 α-Syn 和总 α-Syn、CCL-2、DJ-1、LF 和 MMP-9。与健康对照组相比,PD 患者基础泪液中的 α-Syn 减少(p=0.0043),而 α-Syn(p<0.0001)和 α-Syn/α-Syn 比值(p<0.0001)增加。α-Syn 和 α-Syn/α-Syn 含量的受试者工作特征曲线下面积分别为 0.70(95%置信区间:0.621-0.774)和 0.72(95%置信区间:0.642-0.792)。PD 患者的基础泪液可能含有可进行非侵入性和廉价检测的生物标志物。

相似文献

1
Oligomeric α-synuclein is increased in basal tears of Parkinson's patients.寡聚化的α-突触核蛋白在帕金森病患者的基础泪液中增加。
Biomark Med. 2019 Aug;13(11):941-952. doi: 10.2217/bmm-2019-0167. Epub 2019 Jul 2.
2
Levels of oligomeric α-Synuclein in reflex tears distinguish Parkinson's disease patients from healthy controls.反射性泪液中的寡聚α-突触核蛋白水平可将帕金森病患者与健康对照者区分开来。
Biomark Med. 2019 Dec;13(17):1447-1457. doi: 10.2217/bmm-2019-0315. Epub 2019 Sep 25.
3
Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.帕金森病患者唾液中异常的总α-突触核蛋白和寡聚体α-突触核蛋白
PLoS One. 2016 Mar 24;11(3):e0151156. doi: 10.1371/journal.pone.0151156. eCollection 2016.
4
Salivary alpha-synuclein in the diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.唾液 α-突触核蛋白在帕金森病和进行性核上性麻痹诊断中的作用。
Parkinsonism Relat Disord. 2019 Jun;63:143-148. doi: 10.1016/j.parkreldis.2019.02.014. Epub 2019 Feb 14.
5
Tears - more to them than meets the eye: why tears are a good source of biomarkers in Parkinson's disease.眼泪——远不止我们看到的那么简单:为什么眼泪是帕金森病生物标志物的良好来源。
Biomark Med. 2020 Feb;14(2):151-163. doi: 10.2217/bmm-2019-0364. Epub 2020 Feb 17.
6
α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.唾液细胞外囊泡中的α-突触核蛋白作为帕金森病的潜在生物标志物
Neurosci Lett. 2019 Mar 23;696:114-120. doi: 10.1016/j.neulet.2018.12.030. Epub 2018 Dec 21.
7
Tear α-synuclein as a biomarker for Parkinson's disease: A systematic review and meta-analysis.α-突触核蛋白作为帕金森病生物标志物的研究:系统评价和荟萃分析。
Optom Vis Sci. 2024 Jul 1;101(7):485-492. doi: 10.1097/OPX.0000000000002168. Epub 2024 Aug 5.
8
Increased alpha-synuclein tear fluid levels in patients with Parkinson's disease.帕金森病患者的α-突触核蛋白脑脊液水平升高。
Sci Rep. 2020 May 22;10(1):8507. doi: 10.1038/s41598-020-65503-1.
9
Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.帕金森病患者的泪液中 α-突触核蛋白和神经丝轻链水平升高,视网膜微血管密度降低。
Geroscience. 2022 Jun;44(3):1551-1562. doi: 10.1007/s11357-022-00576-6. Epub 2022 Apr 28.
10
Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.唾液α-突触核蛋白作为帕金森病的生物标志物:系统评价。
J Neural Transm (Vienna). 2019 Nov;126(11):1373-1382. doi: 10.1007/s00702-019-02062-4. Epub 2019 Aug 10.

引用本文的文献

1
Serum and tear autoantibodies from NOD and NOR mice as potential diagnostic indicators of local and systemic inflammation in Sjögren's disease.来自非肥胖糖尿病(NOD)小鼠和正常(NOR)小鼠的血清及泪液自身抗体作为干燥综合征局部和全身炎症的潜在诊断指标。
Front Immunol. 2025 Jan 28;15:1516330. doi: 10.3389/fimmu.2024.1516330. eCollection 2024.
2
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies.生物流体中突触核蛋白病前驱期病理性 α-突触核蛋白的检测。
J Parkinsons Dis. 2024;14(s2):S323-S331. doi: 10.3233/JPD-230429.
3
Reduced tear fluid production in neurological diseases: a cohort study in 708 patients.
神经病变性疾病泪液生成减少:708 例患者的队列研究。
J Neurol. 2024 Apr;271(4):1824-1836. doi: 10.1007/s00415-023-12104-3. Epub 2023 Dec 8.
4
NanoLC-timsTOF-Assisted Analysis of Glycated Albumin in Diabetes-Affected Plasma and Tears.纳米液相色谱-串联飞行时间质谱辅助分析糖尿病患者血浆和泪液中的糖化白蛋白。
J Am Soc Mass Spectrom. 2024 Jan 3;35(1):106-113. doi: 10.1021/jasms.3c00331. Epub 2023 Nov 28.
5
Investigation of Inter- and Intra-Day Variability of Tear Fluid Regarding Flow Rate, Protein Concentration as well as Protein Composition.关于泪液流速、蛋白浓度和蛋白组成的日间和日内变异性研究。
Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):13. doi: 10.1167/iovs.64.13.13.
6
Smart Contact Lenses as Wearable Ophthalmic Devices for Disease Monitoring and Health Management.智能隐形眼镜作为用于疾病监测和健康管理的可穿戴眼科设备。
Chem Rev. 2023 Oct 11;123(19):11488-11558. doi: 10.1021/acs.chemrev.3c00290. Epub 2023 Sep 25.
7
How should we be using biomarkers in trials of disease modification in Parkinson's disease?我们应该如何在帕金森病疾病修饰治疗的临床试验中使用生物标志物?
Brain. 2023 Dec 1;146(12):4845-4869. doi: 10.1093/brain/awad265.
8
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?α-突触核蛋白的翻译后修饰:帕金森病治疗的潜在靶点?
Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023.
9
Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research.帕金森病管理中有前景的生物标志物和治疗靶点:最新进展与当代研究
Metab Brain Dis. 2023 Mar;38(3):873-919. doi: 10.1007/s11011-023-01180-z. Epub 2023 Feb 20.
10
Pre-analytical sample handling effects on tear fluid protein levels.分析前样本处理对泪液蛋白水平的影响。
Sci Rep. 2023 Jan 24;13(1):1317. doi: 10.1038/s41598-023-28363-z.